Tandlæge Kirsten Søndergaard ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.4% 2.7% 1.6% 2.5% 1.7%  
Credit score (0-100)  55 60 73 62 72  
Credit rating  BBB BBB A BBB A  
Credit limit (kDKK)  0.0 0.0 7.2 0.0 4.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,655 1,686 1,965 1,771 1,934  
EBITDA  -82.3 185 521 207 599  
EBIT  -287 -21.5 242 -12.7 372  
Pre-tax profit (PTP)  -330.1 -78.5 181.2 -61.8 363.8  
Net earnings  -263.1 -66.9 135.9 -327.7 103.7  
Pre-tax profit without non-rec. items  -330 -78.5 181 -61.8 364  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  3,555 3,481 3,636 3,166 3,034  
Shareholders equity total  4,276 4,098 4,121 3,679 3,665  
Interest-bearing liabilities  0.0 16.8 0.0 238 180  
Balance sheet total (assets)  5,211 5,265 5,423 4,720 4,907  

Net Debt  -349 -518 -564 -229 -645  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,655 1,686 1,965 1,771 1,934  
Gross profit growth  0.0% 1.9% 16.5% -9.8% 9.2%  
Employees  2 2 2 2 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,211 5,265 5,423 4,720 4,907  
Balance sheet change%  0.0% 1.0% 3.0% -13.0% 4.0%  
Added value  -82.3 185.3 520.8 266.1 598.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  4,490 -341 -184 -750 -419  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 1.0 -1.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -17.4% -1.3% 12.3% -0.7% 19.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -5.5% -0.4% 4.5% -0.3% 7.8%  
ROI %  -6.2% -0.5% 5.4% -0.3% 8.4%  
ROE %  -6.2% -1.6% 3.3% -8.4% 2.8%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  81.9% 77.8% 76.0% 77.9% 74.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  424.3% -279.6% -108.4% -110.9% -107.7%  
Gearing %  0.0% 0.4% 0.0% 6.5% 4.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 679.7% 724.0% 41.2% 4.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.8 0.8 0.8 1.2 1.4  
Current Ratio  0.9 0.9 0.8 1.3 1.4  
Cash and cash equivalent  349.3 535.0 564.4 467.5 824.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -77.4 -116.0 -187.2 127.2 271.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -41 93 260 133 299  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -41 93 260 103 299  
EBIT / employee  -144 -11 121 -6 186  
Net earnings / employee  -132 -33 68 -164 52